AMANDA MORRIS: Open Payments
NPI 1902999733 · GERMANTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,160 in 157 payments from 20 companies in 2025. Trend: 2023 $635 · 2024 $1,006 · 2025 $2,160
Food & beverage: $2,160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $469 |
| AstraZeneca Pharmaceuticals LP | 16 | $373 |
| Novo Nordisk Inc | 20 | $246 |
| Bayer Healthcare Pharmaceuticals Inc. | 19 | $185 |
| PFIZER INC. | 13 | $180 |
| Lilly USA, LLC | 11 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $146 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| Amgen Inc. | 4 | $68 |
| Merck Sharp & Dohme LLC | 3 | $45 |
Products named: VRAYLAR, Kerendia, QULIPTA, NURTEC ODT, FARXIGA, AIRSUPRA, ENTYVIO, MOUNJARO.
Industry payments across OH — which companies pay providers there.
